Blend
BPC + TB
Size
Research Profile
BPC + TB
Literature-based research context for laboratory reference only.
BPC+TB is a research blend combining BPC-157 and TB-500. The combination is studied for complementary mechanisms — BPC-157's cytoprotective and neurotrophic effects alongside TB-500's actin-sequestering and angiogenic properties.
Selected literature
- Sikiric et al., 2018, Current Pharmaceutical Design.
- Goldstein et al., 2012, Annals of the New York Academy of Sciences.
This page is provided for laboratory reference and literature review only. The material is not presented as a consumer product, medical treatment, diagnostic tool, or recommendation for human or animal use.
Overview
BPC + TB is presented here as a laboratory reference entry. The Research Profile summarizes literature-based biological context, while this Overview documents the identity record, specification set, preparation format, and quality-reference information available on the page.
The identity block lists a blend identity rather than a single CAS number, molecular formula Blend, and molecular weight Blend. The material record is paired with ≥99% purity information and a lyophilized presentation for reference review.
Available specification labels include 10mg（5mg/5mg） and 20mg（10mg/10mg）. The active selection is 10mg（5mg/5mg）; changing the selector updates the visible specification label and COA lot references while preserving the same research-reference context.
For the active selection, the page currently shows 1 active COA lot reference. COA links, when present, are retained for batch-level purity, identity, and quantity review, while packaging and storage details remain separated in Structure & Identity.